The sale of a subsidiary often leads to a positive market reaction as it can provide a company with a significant cash infusion and the potential to streamline operations. The substantial increase in stock price reflects investor optimism about the deal's financial benefits to Guardion Health Sciences. However, the deal's closure is subject to stockholder approval, and the final impact will depend on the successful completion of the transaction.